Of relevance is also the overexpression of CD58, CSF1, CD74, and FCGR2B, which have been implicated in RA and OA pathogenesis (96–99) and regarded as potential therapeutic targets (96, 100, 101). The gene discussed is CD58; the disease is rheumatoid arthritis.